Skip to main content
. Author manuscript; available in PMC: 2018 Mar 13.
Published in final edited form as: Aliment Pharmacol Ther. 2017 Mar 8;45(9):1201–1212. doi: 10.1111/apt.14021

Figure 2.

Figure 2

Annual HCV regimens initiated by clinical characteristics (A), regimens achieving SVR by clinical characteristics using observed SVR data (B) or observed and imputed SVR data (C). Treatment and cure rates increased substantially in all patient subgroups, including previously “difficult-to-treat” patients such as those with cirrhosis, but the most profound increase occurred in older patients (age >60 years).